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Abstract
Wnt/b-catenin signaling induced by the Norrin/Frizzled-4 pathway has been shown to improve capillary repair following
oxygen induced retinopathy (OIR) in the mouse, a model for retinopathy of prematurity. Here we investigated if treatment
with the monovalent cation lithium that has been shown to augment Wnt/b-catenin signaling in vitro and in vivo has similar
effects. In cultured human microvascular endothelial cells, LiCl as well as SB 216763, another small molecule that activates
Wnt/b-catenin signaling, induced proliferation, survival and migration, which are all common parameters for angiogenic
properties in vitro. Moreover, treatment with both agents caused an increase in the levels of b-catenin and their
translocation to nuclei while quercetin, an inhibitor of Wnt/b-catenin signaling, completely blocked the effects of LiCl on
proliferation. In mice with OIR, intraperitonal or intravitreal treatment with LiCl markedly increased the retinal levels of b-
catenin, but did not improve capillary repair. In contrast, repair was significantly improved following intravitreal treatment
with Norrin. The effects of LiCl on HDMEC in vitro have minor relevance for OIR in vivo, and the influence of the Norrin/
Frizzled-4 pathway on capillary repair in OIR is not reproducible upon enhancing Wnt/b-catenin signaling by LiCl treatment
strongly indicating the presence of additional and essential mechanisms.
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Introduction
Ischemic retinal diseases, such as diabetic retinopathy or
retinopathy of prematurity, are among the leading cause of
blindness in developed countries [1]. Retinal ischemia is caused by
lack or loss of capillaries, a scenario which activates the typical
hypoxia response leading to an increase in the expression of
angiogenic molecules such as vascular endothelial growth factor
(VEGF). The increase in angiogenic molecules does not lead to a
restoration of the normal retinal capillary bed, but rather causes
retinal neovascularization, a condition in which newly formed
vessels grow along the retina and into the vitreous. Vitreous
hemorrhages or fluid exudation from newly formed or existing
vessels are frequent complications. VEGF is the factor which is
primarily involved in vascular proliferation during retinal neovas-
cularization and the increase in vascular permeability [2,3,4,5].
Current therapeutic options such as photocoagulation or applying
antibodies against VEGF aim at improving oxygen supply to the
inner retina or at blocking the effects of VEGF [5,6]. So far, no
treatment is available that promotes regrowth of functional
capillaries into ischemic retinal areas.
During development, the formation of retinal capillaries
depends on signaling pathways that differ between the different
capillary beds of the retina. The initial outgrowth of capillaries on
the retinal surfaces is largely driven by VEGF which is mainly
released from retinal astrocytes [7,8]. In contrast, capillary
formation in the deep vascular plexus of the retina depends on
an essential signaling system involving the secreted signaling
molecule Norrin, its receptor Frizzled-4, and the activation of
canonical Wnt/b-catenin signaling [9,10,11,12]. Accordingly,
Norrin or Frizzled-4-deficient mice develop capillaries on the
retinal surface, but lack intraretinal capillaries [13,14,15]. In
previous work, we showed that the transgenic overexpression of
Norrin rescues the phenotype of Norrin-deficient mice without
causing retinal neovascularization [13]. Moreover, Norrin pro-
tected mice against oxygen-induced vascular loss after oxygen-
induced retinopathy (OIR), an animal model for retinopathy of
prematurity [16]. In mice, OIR is generated by an exposure to
75% oxygen from postnatal day (P)7 to P12 to induce an
obliteration of the central retinal vasculature [17]. After oxygen
exposure, vessels regrow into vaso-obliterated areas and preretinal
neovascular tufts form [17]. After induction of an OIR in mice
with a transgenic overexpression of Norrin in the lens, Norrin
enhances vessel regrowth into vaso-obliterated areas und promotes
the formation of intraretinal vessels [16]. This effect was
substantially diminished in mice with an additional treatment of
DKK-1, an inhibitor of Wnt/b-catenin signaling [16]. In addition,
the number of preretinal neovascular tufts was markedly reduced
[16]. In human patients, the formation of preretinal neovascular
tufts is a severe complication of retinopathy of prematurity or
diabetic retinopathy.
Since the protective effects of Norrin in OIR required the
activity of canonical Wnt/b-catenin signaling, we wondered if this
pathway has the potential to be used for capillary regrowth and/or
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Figure 1. LiCl and SB 216763 activate the canonical Wnt/b-catenin pathway in HDMEC. A, B, E, F. Western Blot analyses (A, E) and relative
densitometry (B, F) for b-catenin in total protein of HDMEC after treatment with LiCl (A, B) or SB 216763 (E, F) for 3 h (mean 6 SEM of 5 independent
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maintenance in the treatment of retinal ischemic diseases. A
molecule that activates canonical Wnt/b-catenin signaling in the
mouse brain upon oral administration [18] is the monovalent
cation lithium which has been used in the treatment of bipolar
disorders for decades [19,20]. Quite intriguingly, delayed chronic
lithium treatment in rats suffering from stroke after permanent
middle cerebral artery occlusion resulted in enhanced blood
oxygenation levels indicating a positive effect on vascular
formation in poststroke animals [21]. Moreover, in a rat model
of myocardial infarction, lithium caused an accumulation of b-
catenin in parallel to a positive effect on capillary density [22].
Lithium has been shown to activate canonical Wnt/b-catenin
signaling in vitro and in vivo, an effect which is thought to involve
the inhibition of the enzyme glycogen synthase kinase-3b (GSK-
3b) which decreases the cytoplasmic b-catenin levels through
phosphorylation-dependent proteasomal degradation
[18,23,24,25]. In the present study, we investigated if activation
of canonical Wnt/b-catenin signaling following treatment with
LiCl induces angiogenic properties in cultured microvascular
endothelial cells and improves capillary recovery following OIR in
mice.
Materials and Methods
Animals
All procedures in this study conformed to the Policies on the
Use of Animals and Humans in Neuroscience Research of the
Society for Neurosciences, and were approved by the local
authority (Regierung der Oberpfalz, Bavaria, Germany; permit
number: 54-2532.1-09/11). All surgery was performed under
isofluorane anesthesia, and all efforts were made to minimize
suffering. Mice were housed under standard laboratory conditions
(12–12 h light-dark cycle, lights on at 6 am, 22uC, and 60%
humidity) with food and water ad libitum.
Oxygen-induced Retinal Damage
At postnatal day (P) 7, FVB/n mice including their mother were
exposed to 75% oxygen for 5 days [17]. After oxygen exposure at
P12, mice were anesthetized with isofluorane (Baxter) and injected
intraperitoneally (i.p.) with LiCl (50 mg/g body weight; Merck) or
phosphate buffered saline (PBS), or treated with an intravitreal
injection of LiCl (10 mg) in one eye whereas the fellow eye received
PBS only. For protein analyses, eyes were enucleated 6 h after
LiCl treatment and dissected retinae were subjected to protein
isolation and western blot analyses. In parallel experiments, mice
were either injected with LiCl (i.p., 50 mg/g body weight) every
12 h from P12 to P14 or intravitreally injected once with LiCl
(10 mg), Norrin (10 ng/ml) or 3 ml SB 216763 (5 mg/ml) after
oxygen exposure. To analyze the effects of LiCl on capillary
regrowth into vaso-obliterated areas at P13 (intravitreal injection)
or P14 (i.p. injection), mice were perfused with FITC-dextran as
previously described [16]. In brief, mice were perfused with FITC-
dextran (TdB Consultancy, Uppsala, Sweden), retinal whole
mounts were isolated and analyzed on a fluorescent microscope
(Axiovision, Carl Zeiss). The total area of the superficial vascular
plexus and the area of vaso-obliteration were measured and
calculated as relative area of vaso-obliteration per total area of the
superficial vascular plexus using the Axiovision software 4.8.2
(Carl Zeiss).
Cell Culture, Proliferation, Viability, Migration
Human dermal microvascular endothelial cells (HDMEC) were
purchased from Promocell (Heidelberg, Germany) and cultured in
supplemented Microvascular Endothelial Cell Growth Medium
(Promocell) containing penicillin (100 U/ml) and streptomycin
(100 g/ml) at 37uC and 5% CO2. For all experiments unsupple-
mented cell culture medium was used. Confluent HDMEC were
incubated for 3 h with LiCl (0.2 mM, 1 mM, 10 mM; Merck) or
SB 216763 (5 mM, 10 mM, 20 mM dissolved in DMSO; Sigma) in
unsupplemented cell culture medium and subjected to western blot
analyses or immunocytochemistry (see below).
Cell proliferation assays were performed by BrdU labeling of
dividing cells according to the manufacturer’s instructions (Roche).
In brief, 4000 HDMEC were seeded in 96-well tissue culture
plates, allowed to attach overnight and incubated with an
unsupplemented cell culture medium that contained BrdU
(10 mM) and LiCl (0.2 mM, 1 mM, 10 mM) with or without
quercetin (10 mM dissolved in DMSO; Sigma), or BrdU (10 mM)
experiments; n$5; *p,0.05; **p,0.01). C, D, G, H. Immunocytochemistry for b-catenin (green) in HDMEC after incubation with 1 mM LiCl (D) or
10 mM SB 216763 (H) for 3 h and untreated controls (C, G). Blue, DAPI staining. Scale bars: 20 mm.
doi:10.1371/journal.pone.0095546.g001
Figure 2. LiCl and SB 216763 induce proliferation of HDMEC
in vitro. Proliferation of HDMEC was quantified after treatment with
NaCl, LiCl and VEGF (A) or SB 216763 (C). In HDMEC, VEGF (50 ng/ml),
LiCl (0.2 mM, 1 mM) and SB 216763 (5 mM, 10 mM) significantly induced
cell proliferation after incubation for 24 h (mean 6 SEM; n$63 from 4
independent experiments; **p,0.01). The effect of LiCl was markedly
blocked by co-incubation with 10 mM quercetin, an inhibitor of Wnt/b-
catenin signaling (B, mean 6 SEM; n$24 from 3 independent
experiments; **p,0.01).
doi:10.1371/journal.pone.0095546.g002
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and SB 216763 (5 mM, 10 mM, 20 mM; dissolved in DMSO). In
addition, control cells were treated with 0.2 or 1 mM NaCl,
50 ng/ml VEGF (Biolegend, London, UK) or DMSO. After 24 h,
cells were fixed and BrdU incorporation was measured by ELISA
at 450 nm (Tecan, Crailsheim, Germany). Cell viability was
investigated by measuring the NADH- and NADPH-dependent
turnover of WST-1 dye according to the manufacturer’s instruc-
tions (Roche). In brief, 4000 HDMEC were seeded in 96-well
tissue culture plates, allowed to attach overnight and incubated in
unsupplemented cell culture medium that contained LiCl
(0.2 mM, 1 mM, 10 mM) or SB 216763 (5 mM, 10 mM,
20 mM). Again, additional control cells were treated with 0.2 or
1 mM NaCl, 50 ng/ml VEGF or DMSO. After 72 h, the medium
was removed and unsupplemented cell culture medium containing
WST-1 was added for 30 min. Extinction was detected at 450 nm
on an ELISA reader (Tecan). Cell migration was quantified by
standard scratch assays as described previously [16]. After
starvation for 6 h without supplement, confluent HDMEC
monolayers were scratched using a 200 ml sterile plastic pipette
tip. Loose cells were removed, followed by an incubation of the
cells with unsupplemented cell culture medium containing
mitomycin C (5 g/ml; Sigma), and LiCl (0.2 mM, 1 mM), NaCl
(0.2 mM, 1mM) or VEGF (50 ng/ml). Sizes of scratched areas
were analyzed after 0 and 18 h of incubation using a phase
contrast microscope (Axiovert M400, Carl Zeiss). Cell migration
was calculated as relative recolonized area (mm2) per length of the
scratch (mm) by using the Axiovision software 4.8.2 (Carl Zeiss).
VEGF ELISA
VEGF ELISA was purchased from Biorbyt (Cambridge, UK)
and was performed in accordance with the manufacturer’s
instructions. In brief, 10.000 HDMEC were cultured on a 96-
well cell culture dish, allowed to attach, starved overnight in
unsupplemented cell culture medium and incubated in unsupple-
mented cell culture medium with 0.2 mM NaCl or 0.2 mM LiCl.
After 24 h, 100 ml of conditioned cell culture medium were
subjected to VEGF ELISA that was measured by an ELISA plate
reader at 450 nm (Tecan).
Figure 3. LiCl and SB 216763 promote HDMEC survival in vitro.
Quantification of HDMEC viability after incubation with NaCl, LiCl and
VEGF (A) or SB 216763 (B) for 72 h. LiCl (0.2 mM, 1 mM) and VEGF
(50 ng/ml) markedly increased HDMEC survival (A) whereas SB 216763
had only a moderate positive effect on cell viability (B; mean6 SEM; n$
32 from 4 independent experiments; **p,0.01).
doi:10.1371/journal.pone.0095546.g003 Figure 4. LiCl increases migration of HDMEC in vitro. A–E. In
confluent HDMEC a scratch was performed and migration of HDMEC
was calculated as recolonized area per length of the scratch after
incubation with LiCl for 18 h (B–D; dashed line mark the areas lacking
cells before incubation; E, mean 6 SEM; n$10 from at least 2
independent experiments; *p,0.05).
doi:10.1371/journal.pone.0095546.g004
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Figure 5. Intraperitoneal LiCl injections activate the Wnt/b-catenin pathway following OIR, but have no influence on vessel
regrowth into vaso-obliterated areas. A–D. Western blot analyses (A, C) and relative densitometry (B, D) for b-catenin in retinal proteins of
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Immunochemistry
For immunocytochemistry, HDMEC were fixed with methanol
for 5 min 3 h after treatment with 1 mM LiCl or 10 mM SB
216763 in unsupplemented cell culture medium. For immunohis-
tochemistry, LiCl-treated FVB/n mice were perfused with 4%
PFA. Enucleated eyes were fixed in 4% PFA for 2 h, embedded in
Tissue Tek (Sakura Finetek) according to standard protocols and
subjected to cryosectioning. Prior to incubation with rabbit anti-b-
catenin antibodies (1:100; Cell Signaling Technology) overnight at
4uC, samples were blocked for 45 min with 0.1 M phosphate
buffer containing 3% bovine serum albumin (BSA) and 0,1%
Triton X-100. After three washes (10 min each) with 0.1 M
phosphate buffer, samples were treated with biotin-labeled goat
anti-rabbit antibodies (1:500; Vector Laboratories) for 1 h.
Following three additional washes, cells were incubated for 1 h
with streptavidin-Alexa 488 Fluor conjugates (1:1000; Invitrogen).
Finally, specimens were washed again three times and mounted in
fluorescent mounting medium containing 1:10 DAPI (Vector
Laboratories). Immunochemical staining was analyzed in the
ApoTome mode of an Axiovision fluorescent microscope (Carl
Zeiss).
Protein Analyses
For western blot analyses of b-catenin levels, total protein was
extracted using RIPA buffer. Homogenized mouse retinae or
HDMEC were dissolved in RIPA buffer, and cellular debris was
removed by centrifugation. Protein concentration was measured
by the BCA (Interchim) method and up to 25 mg of total proteins
were subjected to a 10% SDS-PAGE. Proteins were subsequently
transferred on a PVDF membrane (Roche) by semidry blotting.
After blocking with 5% low fat milk in TBS-T, the PVDF
membranes were incubated overnight at 4uC with rabbit anti-b-
catenin antibodies (Cell Signaling Technology), diluted 1:1000, in
TBS-T with 0.5% low fat milk. HRP-conjugated chicken anti-
rabbit antibodies (Santa Cruz Biotechnology) were used as
secondary antibodies at a 1:2000 dilution in TBS-T with 0.5%
low fat milk. Antibody labeling was visualized using the
Immobilon HRP substrate (Millipore). For documentation a
LAS 3000 Imager work station (Fujifilm) was used. HRP-
conjugated anti-GAPDH antibodies (Rockland) were applied as
loading control.
Statistics
All values are expressed as mean 6 SEM. Comparisons
between the mean variables of 2 groups were made by a two-
tailed Student’s t-test. P-values less than 0.05 were considered to
be statistically significant.
Results
LiCl and SB 216763 Activate the Wnt/b-catenin Pathway
in HDMEC
To analyze if LiCl or SB 216763 which similarly block the
activity of GSK-3b on b-catenin degradation [26] both activate
the canonical Wnt/b-catenin signaling pathway in human dermal
microvascular endothelial cells (HDMEC), immunohistochemistry
and western blot analyses were performed. After an incubation of
HDMEC with LiCl for 3 h, specific bands for b-catenin were
detected in isolated cellular proteins. By densitometry, the
incubation of HDMEC with 0.2 mM or 1 mM LiCl caused an
increase in b-catenin of up to 1.9- or 1.3-fold, respectively (Fig. 1A,
B). In contrast, following treatment with 10 mM LiCl, a 25%
decrease of b-catenin amounts was detected when compared with
untreated controls (Fig. 1A, B). After incubation of HDMEC with
SB 216763, a more substantial increase in the amounts of b-
catenin was detected by western blot analyses (Fig. 1E). Densi-
tometry showed a significant 3.1- or 4.8-fold increase after
treatment of the cells with 5 mM or 10 mM SB 216763,
respectively (Fig. 1F). To confirm that treatment of HDMEC
with LiCl or SB 216763 not only induced an accumulation of
cytoplasmic b-catenin but also lead to its translocation into the
nucleus, immunohistochemistry for b-catenin was performed. In
untreated control cells, a weak cytoplasmic signal for b-catenin
was detected in addition to a moderate signal close to the cell
membrane (Fig. 1C, G). After treatment of HDMEC with LiCl,
the cell membrane-associated signal for b-catenin became
considerably weaker (Fig. 1D, arrowheads) and a distinct signal
was now observed in the perinuclear cytoplasm and the nucleus
(Fig. 1D, arrow). Treatment with SB 216763 for 3 h did not
change the intensity of the b-catenin signal at the cell membrane
(Fig. 1G, H; arrowheads). In addition, a strong increase in nuclear
b-catenin staining was observed (Fig. 1H; arrow), indicating a
substantial translocation of b-catenin into the nucleus. Overall, our
data strongly suggested that treatment with both LiCl and SB
216763 caused a dose-dependent activation of the Wnt/b-catenin
signaling pathway. Treatment with SB 216763 appeared to have
stronger effects than LiCl.
LiCl Induces Proliferation of Microvascular Endothelial
Cells in vitro via Wnt/b-catenin Signaling
To determine whether LiCl promotes angiogenic properties in
microvascular endothelial cells in vitro, proliferation, survival and
migration of HDMEC were analyzed. Proliferation of HDMEC
was investigated by BrdU ELISA. In cells that were incubated with
0.2 mM or 1 mM NaCl for negative control no increase in BrdU
uptake was observed (Fig. 2A). However, cultivation of HDMEC
with VEGF (50 ng/ml) induced proliferation of more than 55%
compared with untreated control cells (Fig. 2A). Treatment with
0.2 or 1 mM LiCl for 24 h caused a significant up to 38% increase
in the amounts of incorporated BrdU when compared to
untreated controls (Fig. 2A). No effect was seen after treatment
of the cells with 10 mM LiCl (Fig. 2A). Intriguingly, when
compared with VEGF-mediated proliferation, the effect of
0.2 mM LiCl on HDMEC was approximately 65% (Fig. 2A).
To investigate if LiCl induces HDMEC proliferation via Wnt/
b-catenin signaling, cells were incubated with LiCl in the presence
of 10 mM quercetin, a specific and potent inhibitor of b-catenin
signaling [27]. Again, a significant proliferative effect on HDMEC
normoxic control FVB/n mice or after exposure to 75% oxygen for five days from P7 and intravitreal PBS injection or i.p. treatment with LiCl at P12. A,
B. In retinal proteins from mice 6 h after oxygen exposure and intravitreal PBS injection no difference in b-catenin protein level were detected when
compared to normoxic control littermates (mean 6 SEM; n = 5 from 2 independent experiments). C, D. In contrast, in LiCl-injected mice a significant
increase of b-catenin levels was observed when compared to PBS treated animals (mean 6 SEM; n = 13 from 3 independent experiments; *p,0.05).
E–I. Representative retinal whole mounts of FVB/n mice that were perfused with FITC-labeled dextran at P14 after induction of OIR and i.p. LiCl
(3650 mg/g body weight, G, I) or PBS injection (F, H). Scale bars: 1000 mm. For quantification the area of vaso-obliteration (red in H, I) was quantified
at P14 and plotted as percentage of total area of the superficial vascular plexus (E). No difference in the area of vaso-obliteration was observed
between treated mice and control animals (mean 6 SEM; n$13 from 4 independent experiments).
doi:10.1371/journal.pone.0095546.g005
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Figure 6. Intravitreal LiCl injections activate the Wnt/b-catenin pathway following OIR, but have no influence on vessel regrowth
into vaso-obliterated areas. A, B. Western blot analyses (A) and relative densitometry (B) for b-catenin in retinal proteins of FVB/n mice after
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was detected following LiCl-treatment. In contrast, no increase in
BrdU-incorporation was observed after combined treatment with
LiCl and quercetin (Fig. 2B), strongly suggesting the involvement
of Wnt/b-catenin signaling in the proliferative effects of LiCl.
exposure to 75% oxygen for five days from P7 and intravitreal application of LiCl (10 mg). After 6 h, in LiCl-injected eyes a significant increase of b-
catenin levels was observed compared to PBS treated animals (mean 6 SEM; n = 11 from 3 independent experiments; *p,0.05). D, E.
Immunohistochemical staining for b-catenin (green) on retinal cryosections from FVB/n mice 6 h after intravitreal LiCl (10 mg) (E) or PBS injection (D)
and oxygen-exposure until P12. After treatment with LiCl (E) an intense accumulation of b-catenin is seen in nuclei of the inner nuclear layer
compared with PBS injected controls (D). Blue, DAPI staining. Scale bars: 50 mm. F–I. Representative retinal whole mounts of FVB/n mice that were
perfused with FITC-labeled dextran at P13 after induction of OIR and intravitreal LiCl (1610 mg; G, I) or PBS injection (F, H). Scale bars: 1000 mm. For
quantification the area of vaso-obliteration (red in H, I) was quantified at P13 and plotted as percentage of total area of the superficial vascular plexus
(C). No difference in the area of vaso-obliteration was observed between treated mice and control animals (mean 6 SEM; n$13 from 3 independent
experiments).
doi:10.1371/journal.pone.0095546.g006
Figure 7. Norrin promotes vessel regrowth into vaso-obliterated areas. A–E. Representative retinal whole mounts of FVB/n mice that were
perfused with FITC-labeled dextran at P13 after induction of OIR and intravitreal Norrin (163 ml; 10 ng/ml; B, D) or PBS injection (A, C). Scale bars:
1000 mm. For quantification the area of vaso-obliteration (red in C, D) was quantified at P13 and plotted as percentage of total area of the superficial
vascular plexus (E). In Norrin-treated mice the area of vaso-obliteration was significantly smaller compared to PBS-injected control animals (mean 6
SEM; n = 11 from 3 independent experiments; **p,0.01).
doi:10.1371/journal.pone.0095546.g007
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Quite intriguingly, quercetin itself significantly decreased the
proliferation of HDMEC compared with untreated control cells
(Fig. 2B).
Finally, we treated HDMEC with SB 216763 to observe a
significant approximately 30% increase in proliferation when
added at concentrations of 5 mM or 10 mM (Fig. 2C). No effect
was observed when 20 mM SB 216763 were added (Fig. 2C).
Taken together our data strongly indicate that an activation of
Wnt/b-catenin signaling by LiCl or SB 216763 induces prolifer-
ation of cultured HDMEC.
LiCl Induces Survival of Microvascular Endothelial Cells
in vitro
To analyze whether LiCl can promote their survival, HDMEC
were incubated with LiCl for 72 h in unsupplemented cell culture
medium. Again, incubation of 0.2 and 1 mM NaCl had no effect
on microvascular endothelial cell viability (Fig. 3A). When
compared with controls, treatment with 0.2 or 1 mM LiCl led
to a significant 20–25% increase in cell survival (Fig. 3A). Likewise,
after incubation with VEGF that was used as positive control, 42%
more cells survive compared with untreated controls (Fig. 3A).
However, treatment of HDMEC with a higher dose of LiCl
(10 mM) had no effect on cell survival compared to control cells
(Fig. 3A). Next we analyzed the effects of SB 216763 treatment on
HDMEC survival. After incubation with 5, 10, or 20 mM SB
216763 for 72 h, a significant up to 15% increase in cell number
was detected when compared with untreated control cells (Fig. 3B).
LiCl Induces Migration of Microvascular Endothelial Cells
in vitro
To investigate the effects of LiCl on migration of HDMEC,
scratch migration assays were performed. In untreated control
cells only a weak migration of cells into the scratch area was seen
(Fig. 4B). Similar observations were made after incubation of
HDMEC with 0.2 or 1 mM NaCl (Fig. 4E). In contrast, after
incubation of HDMEC with LiCl the number of invading cells was
obviously higher than in untreated controls (Fig. 4C, D). The
strongest effect on HDMEC migration was seen after treatment
with VEGF that was used as positive control. Quantification
showed that following incubation with 0.2 or 1 mM LiCl
migration of HDMEC was significantly increased by 56% and
38%, respectively (Fig. 4E), compared with untreated controls. In
addition, the LiCl-induced effect (0.2 mM) on microvascular
endothelial cell migration was 70% of that caused by VEGF
treatment (Fig. 4E).
LiCl Treatment dose not Induce VEGF Expression
Since there is evidence that the activation of Wnt/b-catenin
signaling enhances the expression of VEGF [28], we wondered if
the effects of LiCl on HDMEC proliferation, viability and
migration could be mediated via an induction of VEGF. To this
end, HDMEC were incubated with 0.2 mM NaCl or 0.2 mM
LiCl for 24 h and a VEGF ELISA was performed using
conditioned cell culture medium. No differences in the relative
VEGF levels were detected between untreated controls
(1.060.02), NaCl- (0.9960.03) or LiCl-treated cells (1.0160.02;
n$15 of 2 independent experiments).
Enhanced Retinal Wnt/b-catenin Signaling Induced by
LiCl or SB 216763 Treatment has No Influence on Vessel
Regrowth Following an Oxygen-induced Damage
To test if the angiogenic properties of LiCl on cultured
HDMEC would increase capillary repair in vivo following damage,
Figure 8. Intravitreal SB 216763 injections activate the Wnt/b-
catenin pathway following OIR, but have no influence on
vessel regrowth into vaso-obliterated areas. A, B. Immunohisto-
chemical staining for b-catenin (green) on retinal cryosections from
FVB/n mice 6 h after intravitreal injection of 3 ml SB 216763 (5 mg/ml) (B)
or DMSO injection (A) and oxygen-exposure until P12. After treatment
with SB 216763 (B) a moderate accumulation of b-catenin is seen in the
inner retina compared with DMSO injected controls (A). Blue, DAPI
staining. Scale bars: 50 mm. C–F. Representative retinal whole mounts of
FVB/n mice that were perfused with FITC-labeled dextran at P13 after
induction of OIR and intravitreal SB 216763 (163 ml; 5 mg/ml; D, F) or
PBS injection (C, E). Scale bars: 1000 mm. For quantification the area of
vaso-obliteration (red in E, F) was quantified at P13 and plotted as
percentage of total area of the superficial vascular plexus (G). No
difference in the area of vaso-obliteration was observed between
treated mice and control animals (mean 6 SEM; n = 6 from 2
independent experiments).
doi:10.1371/journal.pone.0095546.g008
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OIR was induced in mice and vessel regrowth into vaso-
obliterated areas was analyzed following treatment with LiCl.
First, we analyzed if an induction of an OIR itself alters retinal
Wnt/b-catenin signaling. After oxygen exposure for 5 days and
additional 6 h after intravitreal PBS injection no difference in
retinal b-catenin protein level was observed when compared with
normoxic controls (Fig. 5A, B). We next investigated the effect of
systemic LiCl administration on the activation of the Wnt/b-
catenin signaling pathway in the retina. Following oxygen
treatment, a specific band for b-catenin was observed by Western
blot analysis of retinal proteins from PBS-injected mice (Fig. 5C).
The signal was more pronounced in LiCl-treated mice and
densitometry indicated a significant 40% increase in the amounts
of b-catenin compared with PBS-injected controls (Fig. 5C, D). To
analyze the effect of an i.p. injection of LiCl on vessel regrowth,
injected mice were perfused with FITC-labeled dextran and
retinal whole-mounts were prepared. At P14 and two days after
oxygen treatment of PBS-injected control animals, a central vaso-
obliterated area was observed spreading alongside the arteries into
the retinal periphery (Fig. 5F and shown in red in Fig. 5H). In
LiCl-injected animals, the vaso-obliterated area was not different
in morphological appearance or size to that of PBS-injected
controls (Fig. 5G and shown in red in Fig. 5I), a finding that was
confirmed by quantitative analysis (Fig. 5E).
Next we investigated the effects of an intravitreal injection of
LiCl. Following oxygen exposure and intravitreal injection of LiCl
(10 mg), an approximate 2-fold increase in the levels of b-catenin
was detected in retinal proteins compared with control eyes that
received PBS only (Fig. 6A, B). We now analyzed by immuno-
histochemistry whether the increase of total b-catenin in retinal
proteins lead to an increase of its presence in retinal nuclei. After
induction of an OIR in PBS-injected control eyes, a distinct signal
for b-catenin was detected in the nuclei of the retinal ganglion cell
layer (GCL), which was weaker in the nuclei of the inner nuclear
(INL) layer (Fig. 6D). In eyes that were intravitreally injected with
LiCl, the immunoreactivity for b-catenin in the GCL was similar
to that of control retinae (Fig. 6E). In contrast to PBS-injected
control animals, LiCl-treated mice showed a substantial increase in
the number of b-catenin-positive nuclei in the inner nuclear layer
(Fig. 6E). Still, the increase in the amounts of b-catenin did not
improve regrowth of capillaries following OIR. In both PBS-
(Fig. 6F, H) and LiCl-injected eyes (Fig. 6G, I), the morphological
appearances and sizes of the vaso-obliterated areas were entirely
similar at P13 (Fig. 6C, F–I). For positive control and since Norrin
has the potential to induce vessel regrowth into vaso-obliterated
areas after oxygen treatment, Norrin (10 ng/ml) or PBS were
injected into the vitreous cavity following an OIR at P12. In
Norrin-treated eyes the vaso-obliterated area was 6% smaller at
P13 compared to PBS-injected control eyes (Fig. 7A–D), a
difference that was statistically significant (p,0.01; Fig. 7E).
Finally, to rule out the possibility that the lack of vessel regrowth
after induction of an OIR and activation of retinal Wnt/b-catenin
signaling by LiCl is due to potential side effects of LiCl, SB 216763
was injected into the vitreous cavity after oxygen treatment. First
we analyzed by immunohistochemistry the potential of SB 216763
to activate Wnt/b-catenin signaling in the retina. Six hours after
SB 216763 injection and termination of oxygen treatment a
moderate increase of b-catenin staining was observed in the inner
retina compared with DMSO-treated controls (Fig. 8A, B). Quite
noteworthy, the activation of Wnt/b-catenin signaling by SB
216763 treatment following OIR did again not enhance vessel
regrowth into vaso-obliterated areas. Morphology and sizes of the
vaso-obliterated areas of SB 216763 injected eyes were entirely
similar to that of PBS-treated controls (Fig. 8C–G).
Discussion
We conclude that treatment with LiCl mediates angiogenic
properties on cultured HDMEC via an activation of b-catenin
signaling, but not in vivo following OIR in the mouse eye. Our
conclusions rest upon (1) the capability of LiCl to activate b-
catenin signaling in cultured HDMEC and in retinal cells in vivo;
(2) the finding that LiCl induces proliferation, migration and
survival in HDMEC and (3) the observation that a LiCl-mediated
retinal activation of b-catenin signaling has no influence on
vascular repair following OIR.
The capability to induce proliferation, migration and survival of
microvascular endothelial cells in vitro are characteristically seen
with agents or molecules that have potent angiogenic properties
in vivo such as VEGF [29,30]. The comparable effects of LiCl and
SB 216763 are most likely mediated via an activation of Wnt/b-
catenin signaling since increased levels of b-catenin were observed
after treatment of the cells, while quercetin, an inhibitor of Wnt/b-
catenin signaling, blocked the effects of LiCl. However, higher
concentrations of LiCl led to reduced b-catenin levels in HDMEC
and a loss of LiCl-mediated proliferation and viability. Since LiCl
at a concentration of 10 mM has the distinct potential to inhibit
the enzymatic GSK-3b activity in vitro [31], the effects of higher
LiCl concentrations on cultured microvascular endothelial cells
are most likely mediated via activation or inhibition of additional
signaling pathways that inhibit Wnt/b-catenin signaling. In
microvascular endothelial cells, the activation of Wnt/b-catenin
signaling is supposed to increase VEGF levels after 24 h [32].
However, in our current study we did not observe increased
VEGF concentrations in conditioned cell culture medium after
treatment of HDMEC with 0.2 mM LiCl for 24 h. In line with
our observations, Guo and coworkers described an enhanced
expression of VEGF in brain endothelial cells only after incubation
with very high concentrations of LiCl such as 10 or more mM
[33]. Since we observed the main effects of LiCl on proliferation
and migration of HDMEC after treatment with concentrations of
0.2 or 1 mM and after incubation for 24 h or less, our data
strongly suggest that those effects are independent from VEGF
signaling.
There are several explanations for the discrepancy between the
in vivo and in vitro findings of our study. First, we might have missed
to administer LiCl or SB 216763 at the most potent concentration
following i.p. or intravitreal injection. We regard this possibility as
unlikely as we observed an accumulation of b-catenin in retinal
proteins at amounts similar to those observed in a previous study
following the intravitreal injection of Norrin [34]. In line, after
treatment of mice with the same concentrations of Norrin we
found an enhanced vessel regrowth into vaso-obliterated areas.
Another possibility relates to the lack of specificity of LiCl or SB
216763. LiCl may act on neuronal signal transmission and
neurotransmitter release through disturbing the homeostasis of
sodium, magnesium and calcium [35]. In addition, LiCl influences
a broad array of transcription factors and intracellular signaling
pathways, in particular that of phosphoinositide 3-kinase, protein
phosphatase 2A and monophosphatase [25,35]. Similar observa-
tions were made for SB 216763 that was shown to additionally
block various protein kinases such as ERK8, CDK2-CyclinA,
DYRK1A or HIPK2 [36]. Also the primary target of LiCl and SB
216763 to cause an accumulation of b-catenin, GSK-3b, has the
distinct potential to affect proliferation, migration, apoptosis or
survival, and differentiation of various subsets of cell types, via
interaction with various transcription factors, metabolic enzymes
and signaling proteins [37,38,39]. Some of these pathways might
have interfered with an in vivo angiogenic activity of LiCl or SB
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216763 induced via GSK-3b inhibition and b-catenin accumula-
tion.
Finally, both inhibitors of GSK-3b enhanced b-catenin levels,
but failed to induce vessel regrowth into vaso-obliterated areas
whereas treatment with Norrin improved vascular repair. It is
tempting to speculate that an accumulation of b-catenin and the
increase in activity of canonical Wnt/b-catenin signaling is
essential, but not sufficient to induce retinal capillary repair in vivo.
In previous work, we could show that inhibition of canonical Wnt/
b-catenin signaling by treatment with dickkopf-1 attenuated the
effects of Norrin on capillary repair after OIR indicating that this
pathway is essential for capillary repair [16]. Still, other and as of
yet unidentified pathways might be directly or indirectly activated
by Norrin to facilitate its effects on capillary repair. Similar
pathways might be also involved in the effects of Norrin on retinal
angiogenesis during the development of retinal capillaries and
appear to be a very interesting target for further studies.
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